In one paragraphArticle in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Takuya TokunagaDepartment of General Thoracic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.ORCID 0009-0008-1885-5775 Yuka IshiharaDepartment of General Thoracic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.
Aya Harada TakedaDepartment of General Thoracic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.ORCID 0000-0002-7982-8104 Yuya TomiokaDepartment of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.ORCID 0009-0006-7067-5064 Ayako NagataDepartment of Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.ORCID 0000-0001-8735-3383 Mayuko KatoDepartment of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.ORCID 0009-0004-9511-6977 Takayuki SuetsuguDepartment of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.
Keiko MizunoDepartment of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.ORCID 0000-0001-6738-7906 Kazuhiro UedaDepartment of General Thoracic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.ORCID 0000-0003-0030-0882 Naohiko SekiDepartment of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.ORCID 0000-0003-4731-7956 Funding
Japan Society for the Promotion of Science 24K11370Japan Society for the Promotion of Science 24K12457Japan Society for the Promotion of Science 24K12641Japan Society for the Promotion of Science 25K12108
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AcrylamidesAdenocarcinoma of LungAniline CompoundsLung NeoplasmsMicroRNAsProto-Oncogene Proteins c-aktPyrimidinesPyrrolesAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorErbB ReceptorsGene Expression Regulation, NeoplasticHumansIndolesMutationProtein Kinase InhibitorsAcrylamidesAniline CompoundscapivasertibEGFR protein, humanErbB ReceptorsIndolesMicroRNAsMIRN126 microRNA, humanosimertinibProtein Kinase InhibitorsProto-Oncogene Proteins c-aktPyrimidinesPyrrolesAKT2capivasertibEGFR mutationmiR-126-3pmolecular pathwayosimertinib
Identifiers
PMID42792909
PMCPMC13606595
What OpenQuestion holds
Textmetadata
Read underepoch 390